
IVRO
Healthcare · Diagnostics & Research · $1.6M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 29, 2020 | Time not confirmed | — | 0.00 | — |
| May 8, 2020 | Time not confirmed | — | 0.00 | — |
| Feb 18, 2019 | Time not confirmed | — | 0.00 | — |
| Dec 12, 2018 | Time not confirmed | — | 0.00 | — |
| Aug 15, 2018 | Time not confirmed | — | 0.00 | — |
| May 15, 2018 | Time not confirmed | — | 0.00 | — |
| Feb 14, 2018 | Time not confirmed | — | -0.00 | — |
InVitro International, Inc. Develops and markets test kits for non-animal testing in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivity based on a…